SG Americas Securities LLC Has $82.47 Million Stake in Elevance Health, Inc. $ELV

SG Americas Securities LLC raised its holdings in Elevance Health, Inc. (NYSE:ELV) by 6,237.6% in the 4th quarter, HoldingsChannel reports. The firm owned 235,253 shares of the company’s stock after purchasing an additional 231,541 shares during the quarter. SG Americas Securities LLC’s holdings in Elevance Health were worth $82,468,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Assenagon Asset Management S.A. increased its stake in shares of Elevance Health by 17.0% in the fourth quarter. Assenagon Asset Management S.A. now owns 529,508 shares of the company’s stock valued at $185,619,000 after buying an additional 76,970 shares in the last quarter. Diversified Trust Co. raised its holdings in shares of Elevance Health by 5.2% in the fourth quarter. Diversified Trust Co. now owns 35,926 shares of the company’s stock valued at $12,594,000 after buying an additional 1,775 shares during the last quarter. Dynamic Advisor Solutions LLC lifted its position in Elevance Health by 1.9% during the 4th quarter. Dynamic Advisor Solutions LLC now owns 6,170 shares of the company’s stock worth $2,163,000 after buying an additional 115 shares in the last quarter. Independence Wealth Advisors LLC bought a new stake in Elevance Health during the 4th quarter worth about $473,000. Finally, Fulton Bank N.A. increased its position in Elevance Health by 5.9% in the 4th quarter. Fulton Bank N.A. now owns 855 shares of the company’s stock valued at $300,000 after acquiring an additional 48 shares in the last quarter. Institutional investors and hedge funds own 89.24% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the stock. Mizuho dropped their target price on shares of Elevance Health from $413.00 to $350.00 and set an “outperform” rating for the company in a research note on Wednesday, March 11th. Wolfe Research set a $425.00 price target on shares of Elevance Health and gave the company an “outperform” rating in a report on Thursday, January 8th. Truist Financial dropped their price objective on shares of Elevance Health from $400.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, February 2nd. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $332.00 price objective on shares of Elevance Health in a report on Thursday, January 29th. Finally, Wall Street Zen lowered Elevance Health from a “buy” rating to a “hold” rating in a research report on Sunday, February 8th. Twelve equities research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Elevance Health presently has a consensus rating of “Moderate Buy” and an average target price of $387.40.

Elevance Health Stock Up 0.2%

Shares of NYSE:ELV opened at $289.88 on Wednesday. The company has a debt-to-equity ratio of 0.70, a current ratio of 1.54 and a quick ratio of 1.54. The stock has a market cap of $63.98 billion, a price-to-earnings ratio of 11.54, a P/E/G ratio of 1.59 and a beta of 0.51. The company has a 50 day moving average of $327.27 and a 200-day moving average of $333.27. Elevance Health, Inc. has a one year low of $273.71 and a one year high of $458.75.

Elevance Health (NYSE:ELV) last announced its quarterly earnings data on Wednesday, January 28th. The company reported $3.33 earnings per share for the quarter, beating the consensus estimate of $3.10 by $0.23. Elevance Health had a net margin of 2.84% and a return on equity of 15.59%. The business had revenue of $49.31 billion for the quarter, compared to analyst estimates of $49.52 billion. During the same period in the prior year, the business posted $3.84 earnings per share. Elevance Health’s revenue was up 9.6% compared to the same quarter last year. Elevance Health has set its FY 2026 guidance at 25.500- EPS. On average, sell-side analysts forecast that Elevance Health, Inc. will post 33.96 earnings per share for the current year.

Elevance Health Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Wednesday, March 25th. Stockholders of record on Tuesday, March 10th will be given a $1.72 dividend. The ex-dividend date is Tuesday, March 10th. This represents a $6.88 annualized dividend and a dividend yield of 2.4%. This is an increase from Elevance Health’s previous quarterly dividend of $1.71. Elevance Health’s dividend payout ratio is 27.39%.

Elevance Health Company Profile

Elevance Health, Inc (NYSE: ELV) is a large U.S.-based health benefits company that provides a broad range of health insurance products and related services. Headquartered in Indianapolis, the company rebranded from Anthem, Inc to Elevance Health in 2022 while continuing to operate consumer-facing health plans under established state and national brands. Gail Boudreaux serves as chief executive officer and president, leading the company’s strategic focus on integrated health care and benefit delivery.

Elevance’s core activities include offering medical and specialty health plans for individuals, employers and government programs, including Medicare and Medicaid managed-care products.